Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MeMed Secures $93M Financing To Commercialize Diagnostics Platform

10 Jan 2022

• By Barnaby Pickering

MeMeds Key testing platform

Related Content

MeMed’s Mission: Pressing Its Fingerprint Against AMR

22 Sep 2021

Exec Chat: MeMed Improves Diagnostics To Combat Antimicrobial resistance

19 Oct 2021

First Test That Predicts Severe Outcomes In COVID-19 Patients Receives CE Mark

27 Jul 2021

Minute Insight: MeMed Announces Viral/Bacterial Infection Differentiation Results, Commercial Partnership

01 Dec 2021

Related Companies

MeMed

Thermo Fisher Scientific

Additional Topics

Financing Coronavirus COVID-19 Deals Commercial Innovation Diagnostics Medical Device

More from Diagnostics

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.